Nephrology
Fresenius Medical Care gains FDA 501(k) clearance for haemodialysis system
February 9, 2024Medical Communications 501(k), FDA, Fresenius Medical Care, Nephrology, dialysis
Fresenius Medical Care has announced that it has received US Food and Drug Administration (FDA) 501(k) clearance for its 5008X …
Calliditas Therapeutics gains FDA approval of Tarpeyo
December 22, 2023Medical Communications Calliditas, FDA, Nephrology, kidneys
Calliditas Therapeutics has announced that the US Food and Drug Administration (FDA) has approved Tarpeyo (budesonide) delayed release capsules to …
FDA approves Mission Therapeutics’ phase 2 clinical trial for acute kidney injury treatment
December 14, 2023Medical Communications FDA, Mission Therapeutics, Nephrology, acute kidney injury, clinical trial
Mission Therapeutics has announced that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application …
AstraZeneca shares results from ZENITH-CKD phase 2b trial for chronic kidney disease and proteinuria treatment
November 6, 2023Research and Development AstraZeneca, CKD, Nephrology, kidney disease, proteinuria
AstraZeneca has announced results from the ZENITH-CKD phase 2b clinical trial for the combination of zibotentan with dapagliflozin for the …
FDA approves Eli Lilly and Boehringer Ingelheim’s Jardiance for chronic kidney disease treatment
September 25, 2023Medical Communications Boehringer Ingelheim, Eli Lilly, FDA, Nephrology, chronic kidney disease
Eli Lilly and Boehringer Ingelheim have announced that the US Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) 10mg …
CHMP gives positive opinion recommending authorisation to GSK’s CKD drug
June 26, 2023Medical Communications CKD, EMA, Nephrology
Global biopharmaceutical company GSK has announced that the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) …
Novartis acquires Chinook Therapeutics for $3.5bn
June 12, 2023Mergers and Acquisitions Chinook Therapeutics, Nephrology, Novartis, kidney disease, pharma
Swiss pharmaceutical company Novartis has entered into an agreement and plan of merger with US-based biopharmaceutical company Chinook Therapeutics for …
NICE recommends Kapruvia for treatment of moderate-to-severe CKD-associated pruritus
May 18, 2023Medical Communications Kapruvia, NICE, Nephrology, chronic kidney disease, pruritus
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics have announced that the National Institute for Health and Care …
NICE recommends Otsuka’s Lupkynis (voclosporin) in combination treatment for active lupus nephritis
May 4, 2023Medical Communications MHRA, NICE, Nephrology, Otsuka Pharmaceuticals, lupus nephritis
Otsuka Pharmaceuticals has announced that the National Institutes for Health and Care Excellence (NICE) has recommended Lupkynis (voclosporin) in combination …
Latest content
FibroFind appoints Lee Borthwick as CEO
